Keyphrases
Oral Tongue Squamous Cell Carcinoma (OTSCC)
100%
Meta-analysis
100%
Sentinel Lymph Node Biopsy
100%
Systematic Meta-analysis
100%
Neck Dissection
100%
N0 Neck
100%
Confidence Interval
62%
Randomized Clinical Trial
37%
Hazard Ratio
37%
Overall Survival
37%
Disease-free Survival
37%
Nodal Recurrence
37%
Risk Ratio
25%
Disease-specific Survival
25%
Patient Survival
12%
Survival Rate
12%
Head-and-neck Cancer
12%
Patient Well-being
12%
Lymph Node Metastasis
12%
Prognostic Factors
12%
Distant Metastasis
12%
Recurrence Rate
12%
Hazard Risk
12%
Surgical Management
12%
Clinical Perspective
12%
Medical Professionals
12%
Grading System
12%
Comparative Clinical Study
12%
Reporting Item
12%
Local Metastasis
12%
Survival Risk
12%
Non-randomized Clinical Trial
12%
Perspective Study
12%
Comprehensive Meta-analysis
12%
Recurrence Risk Ratio
12%
Robust Guidance
12%
Medicine and Dentistry
Mouth Squamous Cell Carcinoma
100%
Neck
100%
Sentinel Lymph Node Biopsy
100%
Meta-Analysis
100%
Systematic Review
100%
Neck Dissection
100%
Randomized Clinical Trials
50%
Hazard Ratio
37%
Overall Survival
37%
Disease Free Survival
37%
Clinical Study
25%
Recurrence Risk
25%
Disease Specific Survival
25%
Recurrent Disease
12%
Survival Rate
12%
Quality of Life
12%
Retrospective Study
12%
Lymph Node Metastasis
12%
Head and Neck Cancer
12%
Prognostic Factor
12%
Distant Metastasis
12%
Local Metastasis
12%
Primary Outcome
12%
Nursing and Health Professions
Mouth Squamous Cell Carcinoma
100%
Meta Analysis
100%
Systematic Review
100%
Sentinel Lymph Node Biopsy
100%
Neck Dissection
100%
Confidence Interval
62%
Hazard Ratio
37%
Overall Survival
37%
Disease Free Survival
37%
Recurrence Risk
25%
Outcome Variable
25%
Disease Specific Survival
25%
Survival Rate
12%
Recurrent Disease
12%
Distant Metastasis
12%
Head and Neck Cancer
12%
Lymph Node Metastasis
12%
Local Metastasis
12%
Quality of Life
12%
Pharmacology, Toxicology and Pharmaceutical Science
Mouth Squamous Cell Carcinoma
100%
Randomized Clinical Trial
50%
Overall Survival
37%
Disease Free Survival
37%
Clinical Study
25%
Recurrence Risk
25%
Disease Specific Survival
25%
Recurrent Disease
12%
Head and Neck Cancer
12%
Survival Rate
12%
Retrospective Study
12%
Distant Metastasis
12%
Lymph Node Metastasis
12%
Local Metastasis
12%